These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22135073)

  • 21. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute ischemic stroke and long-term outcome after thrombolysis: nationwide propensity score-matched follow-up study.
    Schmitz ML; Simonsen CZ; Hundborg H; Christensen H; Ellemann K; Geisler K; Iversen H; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
    Stroke; 2014 Oct; 45(10):3070-2. PubMed ID: 25190440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy.
    Heuschmann PU; Kolominsky-Rabas PL; Roether J; Misselwitz B; Lowitzsch K; Heidrich J; Hermanek P; Leffmann C; Sitzer M; Biegler M; Buecker-Nott HJ; Berger K;
    JAMA; 2004 Oct; 292(15):1831-8. PubMed ID: 15494580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men.
    Arenillas JF; Sandoval P; Pérez de la Ossa N; Millán M; Guerrero C; Escudero D; Dorado L; López-Cancio E; Castillo J; Dávalos A
    Stroke; 2009 Feb; 40(2):344-9. PubMed ID: 19109538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
    Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
    Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of primary stroke center certification on location of acute ischemic stroke care in Georgia.
    Switzer JA; Akinwuntan A; Waller J; Nichols FT; Hess DC; Bruno A
    Stroke; 2012 May; 43(5):1415-7. PubMed ID: 22363063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization.
    Man S; Cox M; Patel P; Smith EE; Reeves MJ; Saver JL; Bhatt DL; Xian Y; Schwamm LH; Fonarow GC
    Stroke; 2017 Feb; 48(2):412-419. PubMed ID: 28008094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke.
    Ovbiagele B; Smith EE; Schwamm LH; Grau-Sepulveda MV; Saver JL; Bhatt DL; Hernandez AF; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):929-35. PubMed ID: 25249561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
    Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
    Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of stroke center certification on rt-PA thrombolysis after acute ischemic stroke in South China from 2015 to 2020.
    Chen Y; Li J; Dang C; Tan S; Ouyang F; Li J; Yu J; Zeng J; Fan Y
    Int J Stroke; 2022 Jun; 17(5):559-565. PubMed ID: 34235984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 40. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
    Uchino K; Massaro L; Hammer MD
    Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.